What is the target blood sugar range on a Continuous Glucose Monitor (CGM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Target Blood Sugar Range on CGM

For most adults with diabetes, the target blood sugar range on CGM is 70-180 mg/dL (3.9-10.0 mmol/L), with a goal of spending more than 70% of time in this range. 1

Core CGM Target Ranges

Time in Range (TIR)

  • Target: >70% of readings between 70-180 mg/dL for most nonpregnant adults with diabetes 1, 2
  • Each 5% incremental increase in TIR provides clinically meaningful benefits 2, 3
  • This target correlates with an A1C goal of <7% and is associated with reduced risk of microvascular complications 1

Time Below Range (TBR) - Hypoglycemia Targets

  • Level 1 hypoglycemia (54-69 mg/dL): <4% of time 1, 2
  • Level 2 hypoglycemia (<54 mg/dL): <1% of time 1, 2
  • Minimizing severe hypoglycemia (<54 mg/dL) is critical as it can cause lasting neurological damage, particularly in children 4

Time Above Range (TAR) - Hyperglycemia Targets

  • Total TAR: <25% of time above 180 mg/dL 2, 3
  • Level 1 hyperglycemia (181-250 mg/dL): included in the 25% total 1
  • Level 2 hyperglycemia (>250 mg/dL): should be minimized as much as possible 1, 2

Additional Key Metrics

Glycemic Variability

  • Coefficient of variation (CV) target: ≤36% 1
  • Some evidence suggests CV <33% provides additional protection against hypoglycemia for patients on insulin or sulfonylureas 1
  • Lower CV may be more important than higher TIR for preventing hypoglycemia in older adults 5

Data Collection Requirements

  • Minimum 14 days of CGM wear with at least 70% active sensor time (approximately 10 days of data) for reliable assessment 1, 2
  • This duration captures sufficient glycemic variability to guide treatment decisions 1, 2

Modified Targets for Special Populations

Older Adults and High-Risk Individuals

  • TIR: >50% (≥12 hours/day) in range 70-180 mg/dL 2
  • TBR: <1% (<15 minutes/day) below 70 mg/dL - more stringent to prevent falls and cognitive impairment 2, 5
  • TAR: <10% (<2 hours, 24 minutes/day) above 250 mg/dL 2
  • These less stringent targets prioritize hypoglycemia avoidance in vulnerable populations 1, 5

Children and Adolescents

  • Same TIR goal of >70% (70-180 mg/dL), but this target is difficult to achieve without automated insulin delivery systems due to irregular lifestyles and day-to-day variability 1, 4
  • Prioritize TBR <5% over achieving TIR >70% in pediatric patients not using automated systems, as hypoglycemia prevention is paramount 4
  • Severe hypoglycemia in children <6 years can adversely affect brain development 1

Pregnant Individuals

  • Different target range: 63-140 mg/dL (3.5-7.8 mmol/L) - narrower than standard targets 2
  • Specific TIR targets differ from non-pregnant individuals to optimize maternal and fetal outcomes 2

Clinical Context and Interpretation

Relationship to A1C

  • TIR >70% typically correlates with A1C <7% 1
  • The Glucose Management Indicator (GMI) provides a calculated A1C estimate from mean CGM glucose 1
  • CGM provides more actionable real-time data than A1C, which only reflects a 2-3 month average and can be affected by anemia, hemoglobinopathies, and pregnancy 2

Normal Physiology Reference

  • In people without diabetes, CGM shows approximately 87% time in 70-140 mg/dL range, with about 12% of time above 140 mg/dL and brief excursions above 180 mg/dL (>15 minutes/day on average) 6
  • This context helps clinicians understand that even individuals without diabetes experience some glucose variability 6

Common Pitfalls to Avoid

  • Don't focus solely on mean glucose - it misses critical information about hypoglycemia and variability 2
  • Don't collect insufficient data - less than 14 days or <70% sensor wear time yields unreliable patterns 1, 2
  • Don't ignore glycemic variability (CV) - high variability increases hypoglycemia risk even with acceptable TIR 1, 5
  • Don't apply one-size-fits-all targets - individualize based on age, comorbidities, hypoglycemia risk, and life expectancy 1, 2
  • Don't overtighten targets in vulnerable populations - this increases hypoglycemia risk without clear benefit 2, 5

Standardized Reporting

Use the Ambulatory Glucose Profile (AGP) as a standardized single-page report that includes all 10 core CGM metrics with visual cues for easy interpretation 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ideal CGM Data Set for Blood Sugar Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Time in range centered diabetes care.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.